Mirena IUD Side Effects and Management

Common Side Effects

• Unscheduled spotting or light bleeding is expected primarily during the first 3-6 months of use and typically decreases with continued use 1
• Approximately half of users experience amenorrhea or oligomenorrhea by 2 years of use 2
• Heavy or prolonged bleeding is uncommon with levonorgestrel IUDs compared to copper IUDs 2
• Emotional lability, weight gain, and acne are potential side effects 3

Bleeding Pattern Changes

• Bleeding generally decreases with continued use of the Mirena IUD 1, 2
• Many women eventually experience only light menstrual bleeding or complete absence of periods (amenorrhea) 1
• Spotting may occur between periods, especially in the first few months 1

When to Seek Medical Attention

• New-onset spotting after a period of stable bleeding warrants evaluation for IUD displacement, sexually transmitted infections or pelvic inflammatory disease, pregnancy, or new pathologic uterine conditions 1, 2

Management of Side Effects

• For irregular bleeding, reassurance that bleeding irregularities are generally not harmful if no underlying problem is identified, and counseling that bleeding patterns typically improve over time 1, 2
• No specific medical treatments are recommended in guidelines for LNG-IUD users with irregular bleeding 2

Important Considerations

• The Mirena IUD is highly effective with a failure rate of less than 1% 3
• The primary mechanism of action is preventing fertilization by inhibiting sperm motility and thickening cervical mucus 3
• The 52-mg levonorgestrel IUD (Mirena) is approved for 5 years, although data suggest effectiveness for up to 7 years 3
• Continuation rates are improved when patients receive proper counseling about expected bleeding patterns 2

Contraindications and Cautions

• Current breast cancer is a contraindication for Mirena IUD use (Category 4 - should not use) 4
• Past breast cancer with no evidence of current disease for 5 years is a caution for Mirena IUD use (Category 3 - risks usually outweigh benefits) 4
• Persistently elevated β-hCG levels or malignant gestational trophoblastic disease are contraindications for Mirena IUD use (Category 4) 4